Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

GENE THERAPY

Cas9 targeting of toxic foci of RNA repeats

Nature Biomedical Engineering volume 5, pages 130–131 (2021)Cite this article

Subjects

The sustained expression of RNA-targeting Cas9 delivered intramuscularly or systemically by adeno-associated viral vectors eliminates pathogenic foci of expanded-repeat transcripts and reverses muscle-disease phenotypes in mouse models of myotonic dystrophy type 1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Systemic administration of Cas9 targeting toxic expanded RNA repeats in mouse models of DM1.

References

  1. Sznajder, Ł. J. & Swanson, M. S. Int. J. Mol. Sci. 20, 3365 (2019).

    Article  CAS  Google Scholar 

  2. Thornton, C. A. Neurol. Clin. 32, 705–719 (2014).

    Article  Google Scholar 

  3. Taneja, K.L., McCurrach, M., Schalling, M., Housman, D. & Singer, R. H. J. Cell Biol. 128, 995–1002 (1995).

    Article  CAS  Google Scholar 

  4. Miller, J. W. et al. EMBO J. 19, 4439–4448 (2000).

    Article  CAS  Google Scholar 

  5. Lin, X. et al. Hum. Mol. Genet. 15, 2087–2097 (2006).

    Article  CAS  Google Scholar 

  6. Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. & Thornton, C. A. J. Clin. Invest. 117, 3952–3957 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Wheeler, T. M. et al. Nature 488, 111–115 (2012).

    Article  CAS  Google Scholar 

  8. Klein, A. F. et al. J. Clin. Invest. 129, 4739–4744 (2019).

    Article  CAS  Google Scholar 

  9. Reddy, K., Jenquin, J. R., Cleary, J. D. & Berglund, J. A. Int. J. Mol. Sci. 20, 4017 (2019).

    Article  CAS  Google Scholar 

  10. Pinto, B. S. et al. Mol. Cell 68, 479–490.e5 (2017).

    Article  CAS  Google Scholar 

  11. Bisset, D. R. et al. Hum. Mol. Genet. 24, 4971–4983 (2015).

    Article  CAS  Google Scholar 

  12. Batra, R. et al. Cell 170, 899–912.e10 (2017).

    Article  CAS  Google Scholar 

  13. Batra, R. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-00607-7 (2020).

  14. Mankodi, A. et al. Science 289, 1769–1773 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France

    Denis Furling

Authors
  1. Denis Furling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Denis Furling.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furling, D. Cas9 targeting of toxic foci of RNA repeats. Nat Biomed Eng 5, 130–131 (2021). https://doi.org/10.1038/s41551-021-00688-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-021-00688-y

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research